Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.

Clicks: 319
ID: 104036
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #12 of 19 articles by views in diabetes & metabolic syndrome

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.PubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31 March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed.We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.
Reference Key
ghosh2020telemedicinediabetes Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ghosh, Amerta;Gupta, Ritesh;Misra, Anoop;
Journal diabetes & metabolic syndrome
Year 2020
DOI
S1871-4021(20)30060-6
URL
Keywords
mers covid-19 sars-co-v-2 sars-cov-1 viral dynamics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.